Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Fang Liu's publication output changed over time?
ScholarIQpublication output · 2011–2022
Output grew0% over the shown period — from 1 works in 2011 to 1 in 2022.
1
1
3
1
1
1
1
1
1
201120132015201620172018201920212022
What are the most-cited papers on Fang Liu?
ScholarIQmost cited works
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study
Xin-Ran Tang, Ying-Qin Li, Shao-Bo Liang, Wei Jiang, Fang Liu, Wen-Xiu Ge, Ling‐Long Tang, Yan-Ping Mao, Qing-Mei He, Xiao-Jing Yang, Yuan Zhang, Xin Wen, Jiän Zhang, Yaqin Wang, Panpan Zhang, Ying Sun, Jing‐Ping Yun, Jing Zeng, Li Li, Lizhi Liu, Na Liu, Jun Ma
The Lancet Oncology. 2018316 Citations
Fibroblast Activation Protein Overexpression and Clinical Implications in Solid Tumors: A Meta-Analysis
Fang Liu, Qi Li, Bao Liu, Jie Liu, Hua Zhang, Dehai Che, Jingyan Cao, Jing Shen, Jianxiong Geng, Yi Bi, LieGuang Ye, Bo Pan, Yan Yu
PLoS ONE. 2015228 CitationsOPEN ACCESS
Lumacaftor/Ivacaftor in Patients Aged 6–11 Years with Cystic Fibrosis and Homozygous for <i>F508del-CFTR</i>
Carlos Milla, Félix Ratjen, Gautham Marigowda, Fang Liu, David Waltz, Margaret Rosenfeld
S93356601. 2017169 CitationsOPEN ACCESS
Epidemiology of Type 2 Diabetic Foot Problems and Predictive Factors for Amputation in China
Yufeng Jiang, Xingwu Ran, Lijing Jia, Chuan Yang, Penghua Wang, Jianhua Ma, Bing Chen, Yanmei Yu, Bo Feng, Lili Chen, Han Yin, Zhifeng Cheng, Zhaoli Yan, Yuzhi Yang, Fang Liu, Zhangrong Xu
S69307409. 2015153 Citations
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2–5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study
John McNamara, Susanna A. McColley, Gautham Marigowda, Fang Liu, Simon Tian, Caroline A. Owen, David Stiles, Chonghua Li, David Waltz, Linda T. Wang, Gregory S. Sawicki
The Lancet Respiratory Medicine. 2019135 Citations
Related on ScholarIQ
Henan Provincial People's Hospital
Institution
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study
Paper
Fibroblast Activation Protein Overexpression and Clinical Implications in Solid Tumors: A Meta-Analysis
Paper
Lumacaftor/Ivacaftor in Patients Aged 6–11 Years with Cystic Fibrosis and Homozygous for <i>F508del-CFTR</i>
Paper
Epidemiology of Type 2 Diabetic Foot Problems and Predictive Factors for Amputation in China
Paper
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2–5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study
Paper